Eureka Forbes shares declined 0.58 per cent to ₹574.90 on the NSE by mid-morning Friday, despite the company reporting its strongest-ever quarterly performance. The stock opened higher at ₹583.85 but faced selling pressure, with sell quantity at 83,028 significantly outweighing buy quantity of 21,093.
The health and hygiene company announced its Q2 FY26 results on Wednesday, reporting revenue growth of 14.9 per cent year-on-year to ₹773.4 crore. Adjusted EBITDA crossed ₹100 crore for the first time, reaching ₹101.6 crore with a lifetime high margin of 13.1 per cent. Profit after tax grew 32 per cent to ₹61.6 crore.
The company achieved its eighth successive quarter of double-digit growth in products business, with high-teens growth driven by water purifiers and robotics. The service business showed acceleration with double-digit AMC bookings growth.
Trading metrics showed ₹10.53 crore worth of shares changing hands with deliverable quantity at 64.40 per cent, indicating genuine investor interest rather than speculative trading. The stock trades well below its 52-week high of ₹655.50 achieved in May 2025.
With 62.56 per cent shareholding held by Advent International, the free float market capitalisation stands at ₹3,934 crore. Despite strong fundamentals and record profitability, profit-booking appears to have weighed on the stock today.
Published on November 14, 2025
